Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amanda Zatta

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Pediatrics|May 30, 2012
Off-label use of recombinant factor VIIa in pediatric patientsZoe K McQuilten, Chris Barnes, Amanda Zatta, et al.
Journal of Molecular and Cellular Cardiology|February 9, 2005
Age-related changes in ischemic tolerance in male and female mouse heartsLaura Willems, Amanda Zatta, Kirsten Holmgren, et al.
ANZ Journal of Surgery|October 24, 2013
Effectiveness of massive transfusion protocols on mortality in trauma: a systematic review and meta-analysisBiswadev Mitra, Gerard O'Reilly, Peter A Cameron, et al.
Journal of Interventional Cardiology|December 17, 2009
Recirculating delivery improves myocardial cell engraftmentMelissa J Byrne, Amanda Zatta, Cesere Galli, et al.
Blood Transfusion = Trasfusione Del Sangue|June 25, 2014
The Australian and New Zealand Haemostasis Registry: ten years of data on off-licence use of recombinant activated factor VIIAmanda Zatta, Zoe Mcquilten, Rangi Kandane-Rathnayake, et al.
Circulation. Heart Failure|June 21, 2011
CXCR4 antagonism attenuates the cardiorenal consequences of mineralocorticoid excessPo-Yin Chu, Amanda Zatta, Helen Kiriazis, et al.
American Journal of Physiology. Heart and Circulatory Physiology|August 28, 2007
PAR-2 activation at the time of reperfusion salvages myocardium via an ERK1/2 pathway in in vivo rat heartsRong Jiang, Amanda Zatta, Hajime Kin, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Pediatrics|May 30, 2012
Off-label use of recombinant factor VIIa in pediatric patientsZoe K McQuilten, Chris Barnes, Amanda Zatta, et al.
Journal of Molecular and Cellular Cardiology|February 9, 2005
Age-related changes in ischemic tolerance in male and female mouse heartsLaura Willems, Amanda Zatta, Kirsten Holmgren, et al.
ANZ Journal of Surgery|October 24, 2013
Effectiveness of massive transfusion protocols on mortality in trauma: a systematic review and meta-analysisBiswadev Mitra, Gerard O'Reilly, Peter A Cameron, et al.
Journal of Interventional Cardiology|December 17, 2009
Recirculating delivery improves myocardial cell engraftmentMelissa J Byrne, Amanda Zatta, Cesere Galli, et al.
Blood Transfusion = Trasfusione Del Sangue|June 25, 2014
The Australian and New Zealand Haemostasis Registry: ten years of data on off-licence use of recombinant activated factor VIIAmanda Zatta, Zoe Mcquilten, Rangi Kandane-Rathnayake, et al.
Circulation. Heart Failure|June 21, 2011
CXCR4 antagonism attenuates the cardiorenal consequences of mineralocorticoid excessPo-Yin Chu, Amanda Zatta, Helen Kiriazis, et al.
American Journal of Physiology. Heart and Circulatory Physiology|August 28, 2007
PAR-2 activation at the time of reperfusion salvages myocardium via an ERK1/2 pathway in in vivo rat heartsRong Jiang, Amanda Zatta, Hajime Kin, et al.
Pageof 1